{{Rsnum
|rsid=6094752
|Gene=NCOA3
|Chromosome=20
|position=47627680
|Orientation=plus
|GMAF=0.03076
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=NCOA3
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 95.6 | 4.4 | 0.0
| HCB | 97.8 | 2.2 | 0.0
| JPT | 99.1 | 0.9 | 0.0
| YRI | 82.9 | 17.1 | 0.0
| ASW | 84.2 | 15.8 | 0.0
| CHB | 97.8 | 2.2 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 84.8 | 15.2 | 0.0
| LWK | 88.1 | 11.9 | 0.0
| MEX | 94.7 | 5.3 | 0.0
| MKK | 84.6 | 14.7 | 0.6
| TSI | 90.1 | 9.9 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20003447
|Title=Nuclear receptor coregulator SNP discovery and impact on breast cancer risk
|OA=1
}}

{{PMID|19470168|OA=1
}} NPAS2 and PER2 are linked to risk factors of the metabolic syndrome.

{{PMID|20180986|OA=1
}} CLOCK is suggested to associate with comorbid alcohol use and depressive disorders.

{{GET Evidence
|gene=NCOA3
|aa_change=Arg218Cys
|aa_change_short=R218C
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs6094752
|overall_frequency_n=579
|overall_frequency_d=10758
|overall_frequency=0.0538204
|n_genomes=2
|n_genomes_annotated=0
|n_haplomes=2
|n_articles=0
|n_articles_annotated=0
|pph2_score=0.269
|nblosum100=8
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}